Federico Vittorio Rossi

Dr. Federico Vittorio Rossi

Laboratori Alchemia Srl

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AQAndrea Francesca Quivelli
Andrea Francesca Quivelli
FRFederico Vittorio Rossi
Federico Vittorio Rossi
CAChiara Alario
Chiara Alario
FSFrancesco Sannicolò
Francesco Sannicolò
PVPaola Vitale
Paola Vitale
Vito CapriatiVito Capriati
Vito Capriati
Dimethindene is a selective histamine H1 antagonist and is commercially available as a racemate. Upon analyzing the synthetic pathways currently available for the industrial preparation of dimethindene, we set up a sustainable approach for the synthesis of this drug, switching from petroleum-based volatile organic compounds (VOCs) to eco-friendly solvents, such as 2-methyltetrahydrofuran (2-MeTHF) and cyclopentyl methyl ether (CPME) belonging to classes 3 and 2, respectively. Beyond decreasing the environmental impact of the synthesis (E-factor: 24.1–54.9 with VOCs; 12.2–22.1 with 2-MeTHF or CPME), this switch also improved the overall yield of the process (from 10% with VOCs to 21–22% with 2-MeTHF or CPME) and remarkably simplified the manual operations, working under milder conditions. Typical metrics applied at the first and second pass, according to the CHEM21 metrics toolkit, were also calculated for the whole synthetic procedure of dimethindene, and the results were compared with those of the classical procedure.